Parkinson\u2019s Disease (PD) is a debilitating neurodegenerative disorder. The age of onset of PD is usually over 60, but it is estimated that one in 10 cases are diagnosed before the age of 50, with slightly more men than women affected.<\/p>\n
The cardinal features of PD are the slowing down of motor function, resting tremor, muscular rigidity, gait disturbances, and postural reflex impairment. The resting tremor occurs when a person\u2019s hands, arms, or legs shake even when they are at rest; action tremor\u00a0occurs with the voluntary movement of a muscle.<\/p>\n
The underlying pathological lesion is the progressive destruction of dopaminergic neurons in the midbrain. There is currently no available treatment to either prevent or slow down this neuronal loss and the resulting dopamine decrease in the midbrain.<\/p>\n
Experimental and epidemiological research has focused on lifestyle, dietary and environmental risk factors, including coffee consumption. Scientists claim that caffeine may reduce the risk of Parkinson’s disease in people who have a gene mutation associated with a movement disorder. Coffee consumption appears to reduce or delay the development of PD and caffeine is most likely the causal factor. In women, however, the interaction between caffeine and hormonal therapy still needs further clarification<\/p>\n
“These results are promising and encourage future research exploring caffeine and caffeine-related therapies to lessen the chance that people with this gene develop Parkinson’s,” said study author Dr. Grace Crotty of Massachusetts General Hospital.<\/p>\n
“It’s also possible that caffeine levels in the blood could be used as a biomarker to help identify which people with this gene will develop the disease, assuming caffeine levels remain relatively stable,” Crotty added in a news release from the journal\u00a0Neurology.<\/p>\n
Previous studies have shown that caffeine may protect against Parkinson’s in people with no genetic risk factors. This new study focused on a mutation in the LRRK2 gene that increases the risk of Parkinson’s.<\/p>\n
Not all people with this gene mutation develop Parkinson’s disease, so scientists are trying to pinpoint other contributing genetic or environmental factors.<\/p>\n
This study compared 188 people with Parkinson’s disease to 180 people without the disease. Both groups had people with and without the LRRK2 gene mutation.<\/p>\n
Among people with the gene mutation, those with Parkinson’s had a 76% lower concentration of caffeine in their blood than those without Parkinson’s. Among people without the mutation, those who had Parkinson’s had a 31% lower concentration of caffeine in their blood than those without Parkinson’s.<\/p>\n
People with Parkinson’s who had the gene mutation consumed 41% less caffeine a day than the people with and without the gene mutation who didn’t have Parkinson’s.<\/p>\n
The study assessed people at one point in time, so it doesn’t help researchers understand any long-term effect caffeine may have on Parkinson’s risk or how it may affect the disease’s progression, Crotty noted.<\/p>\n
Also, the study doesn’t prove that caffeine consumption directly reduces the risk of Parkinson’s, it only shows an association.<\/p>\n